Back to case studies

InheriNext: website, branding and informational architecture for Genomics AI Platform

Overview

InheriNext is a genomics platform for analyzing hereditary disease data. The company built the technology in Taiwan and needed to enter the US market for Series A funding.

The website was built for Taiwan and had zero search visibility in the US. With a major conference in San Francisco two months away, they needed a site that explained the platform to clinicians and investors.

Visit website

link to website
Client
Compass Bioinformatics
Industry
Genomics / Bioinformatics
Budget
NDA
Timeline
January 2025 - August 2025
Our expertise
Website Architecture
SEO Strategy
Technical Optimization
Content Strategy
Link Building
Team
Senior Architect
Senior Designer
UX/UI Designer
SEO Lead
Content Manager
Copywriter
Outreach Specialist

Result

We repositioned InheriNext for the US market through brand messaging, UX/UI design, and information architecture.

Production wireframes translated genomics technology into accessible experience for American clinicians and investors.

After the San Francisco conference launch, our SEO campaign brought them from zero visibility to first page rankings in four months — digital credibility that supported their $4 million Series A round.

First Page Rankings

Reached #1 for "genetic testing software" within four months of launching the SEO campaign.

Market Positioning

Brand messaging and UX design translated platform into experience that resonated with American clinical audiences.

Conference Ready

Production wireframes and site architecture delivered in two months — launched before the San Francisco conference.

Market Validation

Search results place InheriNext alongside legacy competitors, giving investors and partners the validation they needed for due diligence.

Challenge

InheriNext had the technology but zero digital presence in the US market. The website was built for Taiwanese audiences and didn't explain the platform's value to American clinicians or investors. Search visibility was nonexistent — potential partners couldn't find the company organically, and there were no credibility signals to support Series A conversations.

The platform analyzes hereditary disease data, a complex topic that requires careful explanation without losing technical accuracy. With a major conference in San Francisco two months away, the company needed a site that communicated genomics technology to specialists and positioned them as a legitimate player in the US market.

After the conference, sustained visibility became critical — investors researching the company needed to see InheriNext ranking alongside established competitors.

Key problems:

SOLUTION

Modular brand system & traffic acquisition

We built this as a two-phase market entry strategy around the conference deadline and investor validation.

Phase 1 focused on rapid website foundation. We mapped complete site architecture — over 50 potential pages — then created production-quality wireframes for five essential pages. The wireframes became the final design that launched before the San Francisco conference. Working with their marketing team, we translated genomics complexity into messaging that resonated with US clinicians. The site captured leads through demo requests and sample data downloads.

Phase 2 launched after the conference and focused on search visibility. We built technical SEO foundation, found specialized genomics copywriters, and produced articles monthly. Authority building positioned InheriNext alongside established competitors in search results. Search visibility supported due diligence — investors and partners could validate the company's market position during their evaluation process.

Key deliverables:

Discover other projects

Polaclub: ecommerce store for instant photo

Read full case

Vona Bride: branding and website for a bridal boutique in Kitchener

Read full case